Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.

Oncology reports 20141201

TAS-102: more than an antimetabolite.

The Lancet. Oncology 20121201

Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.

Ophthalmology 20121001

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.

The Lancet. Oncology 20121001

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours.

British journal of cancer 20120724

Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.

Current eye research 20120701

Involvement of concentrative nucleoside transporter 1 in intestinal absorption of trifluorothymidine, a novel antitumor nucleoside, in rats.

The Journal of pharmacology and experimental therapeutics 20120201

Viral infection in renal transplant recipients.

TheScientificWorldJournal 20120101

Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.

PloS one 20120101

A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.

PloS one 20120101

Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats.

Drug development and industrial pharmacy 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Highly regioselective synthesis of 3'-O-acyl-trifluridines catalyzed by Pseudomonas cepacia lipase.

Applied biochemistry and biotechnology 20111101

Unilateral keratitis following death of a twin as the presenting sign of herpetic infection in a neonate.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20111001

Mode of action of trifluorothymidine (TFT) against DNA replication and repair enzymes.

International journal of oncology 20110701

Ocular vaccinia: a consequence of unrecognized contact transmission.

Military medicine 20110601

Herpes keratitis in a patient undergoing treatment with topical mitomycin C.

Cornea 20110401

Evaluation of therapeutic interventions for vaccinia virus keratitis.

The Journal of infectious diseases 20110301

Treatment of viral conjunctivitis with antiviral drugs.

Drugs 20110212

In vitro synergism of trifluorothymidine and ganciclovir against HSV-1.

Investigative ophthalmology & visual science 20110201

Photographic monitoring of herpes simplex virus keratitis during anti-inflammatory treatment.

Archives of ophthalmology (Chicago, Ill. : 1960) 20110201

Inhibition of viral replication in vitro by antiviral-treated amniotic membrane. Possible use of amniotic membrane as drug-delivering tool.

The British journal of ophthalmology 20110101

Inflammatory glaucoma.

Oman journal of ophthalmology 20110101

Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents.

Frontiers in microbiology 20110101

Combination therapies in ophthalmology: implications for intravitreal delivery.

Journal of ophthalmic & vision research 20110101

Antiviral activity of 2,3'-anhydro and related pyrimidine nucleosides against hepatitis B virus.

Bioorganic & medicinal chemistry letters 20101115

Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.

Journal of medicinal chemistry 20101014

Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs.

Aging 20101001

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

Cancer chemotherapy and pharmacology 20100801

Historical perspectives in the development of antiviral agents against poxviruses.

Viruses 20100601

Prodrug activation by Cryptosporidium thymidine kinase.

The Journal of biological chemistry 20100521

Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.

International journal of cancer 20100515

Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer.

Oncology reports 20100501

Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleoside transporter expression or increased secretory phospholipase A2.

Molecular cancer therapeutics 20100401

Quantitative organ time activity curve extraction from rodent PET images without anatomical prior.

Medical physics 20100401

Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines.

Cancer science 20100201

Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3.

Current chemical genomics 20100101

Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.

BMC cancer 20100101

Structure activity relationship of dendrimer microbicides with dual action antiviral activity.

PloS one 20100101

Topical ganciclovir in the treatment of acute herpetic keratitis.

Clinical ophthalmology (Auckland, N.Z.) 20100101

Simple and rapid enzymatic method for the synthesis of single-strand oligonucleotides containing trifluorothymidine.

Nucleosides, nucleotides & nucleic acids 20100101

Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

The Cochrane database of systematic reviews 20100101

Slitlamp biomicroscopy and photographic image analysis of herpes simplex virus stromal keratitis.

Archives of ophthalmology (Chicago, Ill. : 1960) 20090201

A human apolipoprotein E mimetic peptide effectively inhibits HSV-1 TK-positive and TK-negative acute epithelial keratitis in rabbits.

Current eye research 20090201

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal of medicinal chemistry 20081113

Synergistic interaction between trifluorothymidine and docetaxel is sequence dependent.

Cancer science 20081101

Synthesis of nucleoside-based antiviral drugs in ionic liquids.

Bioorganic & medicinal chemistry letters 20081015

Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model.

Investigative ophthalmology & visual science 20081001

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors.

Investigational new drugs 20081001

Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.

Cancer investigation 20081001

[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.

British journal of cancer 20080805

Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.

International journal of pharmaceutics 20080709

Trifluorothymidine induces cell death independently of p53.

Nucleosides, nucleotides & nucleic acids 20080601

Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201

Therapeutic interventions for herpes simplex virus epithelial keratitis.

The Cochrane database of systematic reviews 20080123

Is herpes simplex virus keratitis a different disease in children?

Clinical & experimental optometry 20080101

Novel cell death mechanisms of trifluorothymidine.

Nucleic acids symposium series (2004) 20080101

Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.

Infectious diseases in obstetrics and gynecology 20080101

Collision induced dissociation studies of alkali metal adducts of tetracyclines and antiviral agents by electrospray ionization, hydrogen/deuterium exchange and multiple stage mass spectrometry.

European journal of mass spectrometry (Chichester, England) 20080101

Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.

Clinical ophthalmology (Auckland, N.Z.) 20071201

Collisionally-induced dissociation of substituted pyrimidine antiviral agents: mechanisms of ion formation using gas phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry.

Journal of the American Society for Mass Spectrometry 20070801

Evidence-based treatment of herpes simplex virus keratitis: a systematic review.

The ocular surface 20070701

Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.

Cancer science 20070601

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.

British journal of cancer 20070129

Therapeutic interventions for herpes simplex virus epithelial keratitis.

The Cochrane database of systematic reviews 20070124

The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.

British journal of cancer 20070115

A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.

Mutation research 20070110

Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine.

European journal of cancer (Oxford, England : 1990) 20070101

Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.

Cornea 20070101

High level glucose increases mutagenesis in human lymphoblastoid cells.

International journal of biological sciences 20070101

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors.

Cancer 20060915

American Society of Clinical Oncology--42nd annual meeting. Poster presentations on leukemia and cytotoxic chemotherapy. 2-6 June 2006, Atlanta, GA, USA.

IDrugs : the investigational drugs journal 20060801

Corneal ulceration associated with naturally occurring canine herpesvirus-1 infection in two adult dogs.

Journal of the American Veterinary Medical Association 20060801

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.

Bioorganic & medicinal chemistry letters 20060215

Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060215

Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.

Cancer chemotherapy and pharmacology 20060101

Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.

American journal of clinical dermatology 20060101

Ocular vaccinia infection in laboratory worker, Philadelphia, 2004.

Emerging infectious diseases 20060101

In vitro comparison of antiviral drugs against feline herpesvirus 1.

BMC veterinary research 20060101

Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells.

BMC bioinformatics 20060101

Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20051201

Herpes simplex keratitis misdiagnosed as rheumatoid arthritis-related peripheral ulcerative keratitis.

Cornea 20051101

Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations.

The Veterinary record 20050827

Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.

International journal of oncology 20050801

Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells.

Anti-cancer drugs 20050301

Multinodular goiter management in Western Saudi Arabia.

Saudi medical journal 20050301

Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.

Retrovirology 20050101

Ocular complications in the Department of Defense Smallpox Vaccination Program.

Ophthalmology 20041101

Association between ocular herpes simplex virus and topical ocular hypotensive therapy.

Journal of glaucoma 20041001

Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.

Nucleosides, nucleotides & nucleic acids 20041001

Intracellular thymidylate synthase inhibition by trifluorothymidine in FM3A cells.

Nucleosides, nucleotides & nucleic acids 20041001

A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.

International journal of oncology 20040901

Herpes simplex virus keratitis in children.

American journal of ophthalmology 20040901

Antiviral drugs in current clinical use.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040601

Pharmacokinetic modeling of species-dependent enhanced bioavailability of trifluorothymidine by thymidine phosphorylase inhibitor.

Drug metabolism and pharmacokinetics 20040601

The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylase.

European journal of pharmacology 20040503

[The latest in herpes simplex keratitis therapy].

Journal francais d'ophtalmologie 20040501

A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.

International journal of molecular medicine 20040401

Arthrographis keratitis mimicking acanthamoeba keratitis.

Cornea 20040401

New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty.

American journal of ophthalmology 20040301

Ocular vaccinia following exposure to a smallpox vaccinee.

American journal of ophthalmology 20040301

Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.

Oncology reports 20040201

An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA.

International journal of molecular medicine 20040201

Management of ophthalmic zoster mucous plaque keratopathy: report of three cases.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20040201

Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study.

Current eye research 20040101

Herpes simplex uveitis.

Boletin de la Asociacion Medica de Puerto Rico 20040101

[Trifluridine therapy in herpetic in keratitis].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20040101

Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.

Cancer gene therapy 20031001

Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.

Bioorganic & medicinal chemistry letters 20030915

Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.

Chembiochem : a European journal of chemical biology 20030804

Ocular complications of smallpox vaccination.

American journal of ophthalmology 20030801

The effect of roscovitine on herpetic keratitis.

Experimental eye research 20030601

In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.

Investigative ophthalmology & visual science 20030601

Management of acyclovir-resistant herpes simplex virus.

Dermatologic clinics 20030401

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.

British journal of cancer 20030324

Detection of thymidylate synthase modulators by a novel screening assay.

Molecular pharmacology 20030101

Recurrence of keratitis after excimer laser keratectomy.

Journal of cataract and refractive surgery 20030101

In vitro activity of potential anti-poxvirus agents.

Antiviral research 20030101

Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.

Current eye research 20030101

Interventions for herpes simplex virus epithelial keratitis.

The Cochrane database of systematic reviews 20030101

Design of Mycobacterium tuberculosis thymidine monophosphate kinase inhibitors.

Nucleosides, nucleotides & nucleic acids 20030101

Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.

Antiviral research 20021101

Drugs for non-HIV viral infections.

The Medical letter on drugs and therapeutics 20020204

Mutation induction in human cells after low dose X ray exposure.

Radiation protection dosimetry 20020101

Positive effect of PRK on Thygeson's keratitis.

Cornea 20011101

Atypical presentation of Acanthamoeba keratitis.

Cornea 20011001

Incorporation of 2'-deoxy-5-(trifluoromethyl)uridine and 5-cyano-2'-deoxyuridine into DNA.

Bioorganic & medicinal chemistry letters 20010917

Antiviral drugs: current state of the art.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801

Influence of radiation sterilization on the stability of trifluorothymidine.

International journal of pharmaceutics 20010717

Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection.

Cornea 20010701

5-(Trifluoromethyl)-beta-l-2'-deoxyuridine, the L-enantiomer of trifluorothymidine: stereospecific synthesis and antiherpetic evaluations.

Bioorganic & medicinal chemistry 20010701

Contact dermatitis from topical antiviral drugs.

Contact dermatitis 20010501

Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit.

American journal of ophthalmology 20010501

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.

Clinical microbiology reviews 20010401

In vitro effects of antiviral agents on human keratocytes.

Cornea 20010101

Interventions for herpes simplex virus epithelial keratitis.

The Cochrane database of systematic reviews 20010101

Synthesis and in vitro activity of D- and L-enantiomers of 5-(trifluoromethyl)uracil nucleoside derivatives.

Nucleosides, nucleotides & nucleic acids 20010101

Efficacy of select antivirals against Cryptosporidium parvum in vitro.

FEMS microbiology letters 19981101

Delivery of trifluridine to human cornea and aqueous using collagen shields.

The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc 19980401

Therapeutic response of herpes simplex virus-induced corneal edema to trifluridine in combination with immunosuppressive agents.

Investigative ophthalmology & visual science 19910801

Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.

Antimicrobial agents and chemotherapy 19870101

Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.

Journal of medicinal chemistry 19860701

Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.

Antiviral research 19850201

Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1.

Journal of medicinal chemistry 19840301

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.

Antimicrobial agents and chemotherapy 19820101

Activity of trifluorothymidine against cytomegalovirus.

Antimicrobial agents and chemotherapy 19810901

(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

Proceedings of the National Academy of Sciences of the United States of America 19790601

Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits.

Antimicrobial agents and chemotherapy 19781201

9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Nature 19780413

Improved synthesis and in vitro antiviral activities of 5-cyanouridine and 5-cyano-2'-deoxyuridine.

Journal of medicinal chemistry 19770701

Nucleosides. 3. Studies on 5-methylamino-2'-deoxyuridine as a specific antiherpes agent.

Journal of medicinal chemistry 19660501